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OBJECTIVE: We aimed to assess the effects of diazoxide on the mortality, pancreatic injury, and inflammatory
response in an experimental model of acute pancreatitis.
METHODS: Male Wistar rats (200–400 g) were divided randomly into two groups. Fifteen minutes before
surgery, animals received physiological (0.9%) saline (3 mL/kg) (control group) or 45 mg/kg diazoxide (treatment
group) via the intravenous route. Acute pancreatitis was induced by injection of 2.5% sodium taurocholate via
the biliopancreatic duct. Mortality (n=38) was observed for 72 h and analyzed by the Mantel–Cox Log-rank test.
To study pancreatic lesions and systemic inflammation, rats (10 from each group) were killed 3 h after acute
pancreatitis induction; ascites volume was measured and blood as well as pancreases were collected. Pancreatic
injury was assessed according to Schmidt’s scale. Cytokine expression in plasma was evaluated by the multiplex
method.
RESULTS: Mortality at 72 h was 33% in the control group and 60% in the treatment group (p=0.07). Ascites
volumes and plasma levels of cytokines between groups were similar. No difference was observed in edema or
infiltration of inflammatory cells in pancreatic tissues from either group. However, necrosis of acinar cells was
lower in the treatment group compared to the control group (3.5 vs. 3.75, p=0.015).
CONCLUSIONS: Treatment with diazoxide can reduce necrosis of acinar cells in an experimental model of acute
pancreatitis, but does not affect the inflammatory response or mortality after 72 h.
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’ INTRODUCTION
Acute pancreatitis (AP) has a broad clinical spectrum,
ranging from mild symptoms to multiple-organ dysfunction
syndrome and death (1, 2). Regardless of cause, AP is char-
acterized by inappropriate activation of pancreatic enzymes,
necrosis of acinar cells, as well as local and systemic inflam-
mation (2–5). Outcome is related to extension of necrosis of
pancreatic tissue and the inflammatory response. In severe
cases, mortality can be high (E15%), particularly if necrotic
tissue becomes infected (2, 6). No specific treatment is
available and, in spite of advances in intensive care and
management of complications, few benefits in the outcome of
this group of patients have been reported (2, 7).
Diazoxide is used as an antihypertensive drug because it
acts on adenosine triphosphate-sensitive potassium (KATP)
channels in the membranes of cells and mitochondria (8).
Nevertheless, it has also been described as possessing an
anti-inflammatory effect as demonstrated in experimental
and clinical research. In rats, diazoxide accelerates recovery
of the mucosa in gastric ulcers (9) and reduces lesions
induced by indomethacin in the small intestine (10). Also,
an anti-inflammatory effect has been demonstrated if dia-
zoxide is administered in patients undergoing coronary
artery bypass grafting (11).
Therefore, considering that AP has an inflammatory com-
ponent and that diazoxide has an anti-inflammatory effect, we
hypothesized that diazoxide administration may modulate the
inflammatory response in an experimental model of severe AP,
thereby improving the outcome and recovery.
The aim of our study was to evaluate the effect of diazoxide
with regard to mortality, pancreatic injury and the inflamma-
tory response in an experimental model of severe AP.
’ MATERIALS AND METHODS
The study protocol was approved by the Ethics Committee
for the Use of Animals of Faculdade de Medicina da
Universidade de São Paulo (protocol number 102/15).DOI: 10.6061/clinics/2017(02)10
Copyright & 2017 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons License (http://creativecommons.org/licenses/by/
4.0/) which permits unrestricted use, distribution, and reproduction in any
medium or format, provided the original work is properly cited.
No potential conflict of interest was reported.
125
RAPID COMMUNICATION
The study group was 58 male Wistar rats (200–400 g).
Animals were handled according to the Guidelines for the
care, handling and use of laboratory animals (National
Institutes of Health, Bethesda, MD, USA, 1985).
Surgical procedures
Rats were anesthetized (ketamine hydrochloride (70 mg/kg
body weight) and xylazine chloride (10 mg/1 g)) and fixed in
the supine position on a platform. They underwent trichotomy
and antisepsis of the abdomen using polyvinylpyrrolidone.
The tail vein was cannulated and animals divided randomly
into two groups before AP induction. The control group
received sterile physiologic (0.9%) saline 15 min before the
surgical procedure. The treatment group received diazoxide
(45 mg/kg) before the procedure.
AP induction
After laparotomy, the duodenal arch and pancreas were
externalized. Identification and occlusion of the bile duct at the
level of the hepatic hilumwas done using a bulldog clamp. The
non-mesenteric portion of the duodenum was punctured with
a needle (25 mm  7 mm). The bile duct was catheterized with
a polyethylene (PE-10) catheter. After catheterization, 0.5 mL of
sodium taurocholate (2.5%) was injected in a retrograde
fashion for 1 min. Then, the catheter was removed, the duo-
denal puncture closed (nylon 6-0), the bulldog clamp removed,
and the abdominal wall closed in layers (nylon 5-0).
The type of severe AP induced by the method used in the
present study is characterized macroscopically by immediate
hyperemia and edema. Later, this macroscopic diagnosis was
confirmed by microscopic assessment.
Mortality curves
To evaluate mortality, animals were observed every 12 h
for 72 h. Animals alive o72 h after AP were killed by
anesthesia. This was followed by exsanguination by section
of the abdominal aorta and inferior vena cava.
Histology and inflammatory cytokines
One group of animals was killed 3 h after AP induction for
the collection of blood samples and pancreatic tissue.
The pancreas was fixed in formalin 10% and embedded in
paraffin. Tissue sections were stained by hematoxylin and
eosin for histopathologic analyses under light microscopy.
Schmidt’s scale was used to classify AP degree (12, 13). This
scale analyses edema, necrosis of acinar cells, fat necrosis,
hemorrhage and inflammatory infiltration.
Expression of inflammatory cytokines in plasma were
assessed using ELISA (Thermo Scientific, Waltham, MA,
USA). Levels of interleukin (IL) 4, 6, 10, 13, as well as tumor
necrosis factor (TNF)a were measured according to manu-
facturer instructions.
Statistical analyses
Data are the mean±standard error or median (interquartile
range), where appropriate. Histologic lesions were evaluated
using the Mann–Whitney test. Expression of inflammatory
mediators and volume of ascites were analyzed by the
Student’s t-test or Mann–Whitney test. For mortality curves,
analyses were by the log-rank test (Mantel–Cox). po0.05 was
considered significant.
’ RESULTS
Mortality curves
Initially, to determine the effect of diazoxide treatment on
mortality, 38 rats (18 in the control group and 20 in the treat-
ment group) underwent AP induction and were observed for
X72 h. After this period, 6 animals (33%) in the control
group had died and 12 animals (60%) in the treatment group
had died (Figure 1), and the difference was not significant
(p=0.076).
Ascites formation and histologic analyses
There was no significant difference in the volume of ascites
collected from control animals and animals treated with
diazoxide (p=0.172).
Histologic analyses of pancreatic tissue after AP induction
in the control group showed considerable interstitial edema,
several hemorrhagic foci, and extensive fat necrosis (Figure 2,
panel A). None of these features were modified by pretreat-
ment with diazoxide (Figure 2, panel B; Table 1).
Figure 1 - Seventy-two hours after induction of acute pancreatitis, mortality was 33% in the control group (n=18) and 60% in animals
that received diazoxide (n=20) (p=0.076, Mantel–Cox test).
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In control animals, acinar necrosis was also prominent, but
it was reduced in the treatment group (Figure 2, 3).
Inflammatory response
A significant difference was not observed in the number of
inflammatory cells in pancreatic tissue after diazoxide
treatment (Table 1).
To assess systemic inflammation, expression of several
cytokines in plasma was measured. Diazoxide treatment did
not affect circulating levels of cytokines linked to the type-1
T-helper cell (Th)1 response (e.g., TNFa) nor cytokines relea-
sed during a Th2 response (e.g., IL10) (Figure 4). Serum levels
of other cytokines (IL1, IL4, IL13) could not be detected by
ELISA in either group.
’ DISCUSSION
We report that, using an experimental model of AP in
Wistar rats, diazoxide can reduce necrosis of acinar cells
without affecting the overall inflammatory response.
The experimental model used in the present study was
effective for AP induction. Sodium taurocholate caused severe
histologic damage similar to that observed for other experi-
mental models (14–16). Significant edema, intense infiltration
of leukocytes and intra-pancreatic bleeding shows the
similarity of the histopathology of experimental lesions with
moderate-to-severe pancreatitis in humans (14, 15). Mortality
in the control group at 24 h was 22%, similar to the mortality
(20%) obtained using glycodeoxycholic acid (5–10 mmol) by
other research teams. The different mortality obtained in the
treatment group could have been related to the effects on
blood pressure because this parameter was not controlled in
our study.
Despite the anti-inflammatory effect of diazoxide shown in
other studies, there was no effect on expression of infla-
mmatory cytokines or pancreatic inflammatory infiltrates in
the present study. This is interesting because, in other models
with a prominent chronic component, such as recovery of the
Figure 2 - Diazoxide decreases necrosis of acinar cells in acute pancreatitis (AP). AP induction caused necrosis of multiple pancreatic
acinar cells (left image). In the group that received diazoxide, there was a significant reduction in the number of necrotic cells (right
image) (n=20 in each group, p=0.015, Mann–Whitney test).
Table 1 - Morphological features of pancreatic injury after AP
induction.
Feature Control Treatment p
Fat necrosis* 2.8±0.3 2.8±0.5 0.791
Inflammatory infiltrate* 3.6±0.1 3.4±0.2 0.247
Interstitial Edema** 4.0 (3.5-4.0) 3.5 (3.5-3.8) 0.382
Hemorrhagic foci** 4.0 (2.6-4.0) 3.5 (3.0-3.8) 0.622
*These features presented a normal distribution, therefore data are
presented as Mean±SEM and the statistic test used was Student’s t-test.
** These features did not present a normal distribution, therefore data
are presented as Median and confidence interval, with the Mann-Whitney
test being used to compare the groups.
Figure 3 - Median acinar necrosis score in control and treatment
groups (diazoxide) (n=20 per group, p=0.015, Mann–Whitney
test).
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mucosa in gastric ulcers (9–11), diazoxide is effective
whereas, in our model (which represents more acute injury),
it was not.
In 20% of cases, AP presents with pancreatic and/or peri-
pancreatic necrosis, the evolution of which is related to the
severity and extent of pancreatic injury and presence/
absence of infection (1, 6, 17, 18). In our experimental model,
diazoxide could reduce necrosis of acinar cells.
Necrotic cell death occurs generally in response to physico-
chemical stress, including hypoxia, ischemia, hypoglycemia,
extreme temperature changes, and nutrient deprivation (19).
All these processes lead to diminished ATP production by
mitochondria, increased glycolisis and intracellular acidification.
The cell answers to the pH drop by activating the Na+/H+
antiporter, increasing intracellular Na+ levels. Since Na+/K+
ATPase is not functioning adequatly, due to lack of
ATP, Na+ accumulates inside the cell (20). The Na+/Ca2+
channel is, then, activated, loading the intracellular millieu
with Ca2+. Citoplasmic Ca2+ enters the mitochondria, which
loose their capacity of controlling intracellular Ca2+, ensuing
cell death (21).
It is known that diazoxide opens KATP channels on the
plasma and mitochondrial membranes (8). This phenomenon
would alleviate the initial intracellular Na+ accumulation,
protecting the cell. Several studies have demonstrated the
importance of mitochondrial KATP for protection of cells
against ischemia, prevention of ATP loss, inhibition of
calcium entry, and reductions in levels of reactive oxygen
species (22). Other investigators have reported that opening
of the mitochondrial permeability pore is involved in AP
pathogenesis because it reduces ATP production and
culminates in tissue necrosis (23).
Diazoxide has also been recently reported to exert
antioxidant effects (24). Since redox inbalance is one of the
main mechanisms responsible for the triggering of cell death,
as observed in ischemia-reperfusion injury (25), we may also
speculate that antioxidant action of diazoxide could be, at
least partially, responsible for our findings. This hypothesis,
however, was not tested in our experiments.
We can, therefore, postulate that the positive effect of
diazoxide in reduction of injury to pancreatic tissue is related
to its action upon the mitochondrial permeability pore.
Use of diazoxide in an experimental model of AP can
reduce the intensity of necrosis of acinar cells.
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